Media Summary: Stephen Liu, MD, director of Thoracic Oncology at Georgetown University, joined Lung Cancers Today to discuss key ... Coral Olazagasti, MD, of the Sylvester Comprehensive Cancer Center, University of Miami, joined Lung Cancers Today to reflect ... Giannis Mountzios, MD, Henry Dunant Hospital, Athens, Greece, discusses patient-reported outcomes from Phase III ...

Imforte And Dellphi 304 Dr - Detailed Analysis & Overview

Stephen Liu, MD, director of Thoracic Oncology at Georgetown University, joined Lung Cancers Today to discuss key ... Coral Olazagasti, MD, of the Sylvester Comprehensive Cancer Center, University of Miami, joined Lung Cancers Today to reflect ... Giannis Mountzios, MD, Henry Dunant Hospital, Athens, Greece, discusses patient-reported outcomes from Phase III ... Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Molly Li, MBBS, of the Chinese University of Hong Kong, joined Lung Cancers Today at the 2025 American Society of Clinical ... Anna Minchom, MD, BCh, MB, MRCP, from The Royal Marsden Hospital, London, UK, discusses the investigation of tarlatamab in ...

In this episode of the Oncology Brothers podcast, we dive deep into the latest advancements in treating extensive stage small cell ... As reported in the Journal of Clinical Oncology by Stephen V. Liu, MD, and colleagues, an updated overall survival analysis in the ... Immunotherapy is changing treatment strategies for both limited- and extensive-stage small cell lung cancer, explained Triparna Sen, PhD, joined Lung Cancers Today at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting to ... Heather A. Wakelee, MD, Stanford University, Stanford, CA, talks on the findings of IMpower010, a Phase III global study of ... ... treatment advances for small cell lung cancer like the

Photo Gallery

IMFORTE and DeLLphi-304: Dr. Stephen Liu on How the ASCO 2025 Data Are Changing the Standard of Care
ASCO 2025: Insights on CheckMate-816, IMforte, and DeLLphi-304 From Coral Olazagasti, MD
PROs from DeLLphi-304 evaluating tarlatamab vs chemotherapy in SCLC
ASCO 2025 Lung Cancer Highlights: CheckMate 816, ToD, NeoADAURA, IMforte, DeLLphi 304
Game-Changer in Small Cell Lung Cancer? Tarlatamab vs Standard Treatment – DeLLphi-304 Phase 3 Trial
Maintenance Lurbinectedin + Atezolizumab Improves Survival Outcomes in ES-SCLC in IMforte Trial
Tarlatamab Phase 3 Results for Relapsed SCLC at ASCO 2025 | DeLLphi-304
IMforte Study Design by Dr. Isabel Preeshagul – Lurbinectedin + Atezolizumab Maintenance in ES-SCLC
Tarlatamab improves symptoms and QoL over chemotherapy in previously treated small cell lung cancer
How New Research is Transforming the Treatment Paradigm for SCLC
IMforte Study Results from ASCO 2025 & WCLC 2025 by Dr. Stephen Liu
Exploring tarlatamab in the DeLLphi-301 trial for small cell lung cancer
Sponsored
Sponsored
View Detailed Profile
IMFORTE and DeLLphi-304: Dr. Stephen Liu on How the ASCO 2025 Data Are Changing the Standard of Care

IMFORTE and DeLLphi-304: Dr. Stephen Liu on How the ASCO 2025 Data Are Changing the Standard of Care

Stephen Liu, MD, director of Thoracic Oncology at Georgetown University, joined Lung Cancers Today to discuss key ...

ASCO 2025: Insights on CheckMate-816, IMforte, and DeLLphi-304 From Coral Olazagasti, MD

ASCO 2025: Insights on CheckMate-816, IMforte, and DeLLphi-304 From Coral Olazagasti, MD

Coral Olazagasti, MD, of the Sylvester Comprehensive Cancer Center, University of Miami, joined Lung Cancers Today to reflect ...

Sponsored
PROs from DeLLphi-304 evaluating tarlatamab vs chemotherapy in SCLC

PROs from DeLLphi-304 evaluating tarlatamab vs chemotherapy in SCLC

Giannis Mountzios, MD, Henry Dunant Hospital, Athens, Greece, discusses patient-reported outcomes from Phase III ...

ASCO 2025 Lung Cancer Highlights: CheckMate 816, ToD, NeoADAURA, IMforte, DeLLphi 304

ASCO 2025 Lung Cancer Highlights: CheckMate 816, ToD, NeoADAURA, IMforte, DeLLphi 304

Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by

Game-Changer in Small Cell Lung Cancer? Tarlatamab vs Standard Treatment – DeLLphi-304 Phase 3 Trial

Game-Changer in Small Cell Lung Cancer? Tarlatamab vs Standard Treatment – DeLLphi-304 Phase 3 Trial

Breakthrough in Small Cell Lung Cancer?

Sponsored
Maintenance Lurbinectedin + Atezolizumab Improves Survival Outcomes in ES-SCLC in IMforte Trial

Maintenance Lurbinectedin + Atezolizumab Improves Survival Outcomes in ES-SCLC in IMforte Trial

First Look With ASCO Daily News presents

Tarlatamab Phase 3 Results for Relapsed SCLC at ASCO 2025 | DeLLphi-304

Tarlatamab Phase 3 Results for Relapsed SCLC at ASCO 2025 | DeLLphi-304

Discover the phase 3

IMforte Study Design by Dr. Isabel Preeshagul – Lurbinectedin + Atezolizumab Maintenance in ES-SCLC

IMforte Study Design by Dr. Isabel Preeshagul – Lurbinectedin + Atezolizumab Maintenance in ES-SCLC

Dr

Tarlatamab improves symptoms and QoL over chemotherapy in previously treated small cell lung cancer

Tarlatamab improves symptoms and QoL over chemotherapy in previously treated small cell lung cancer

Dr

How New Research is Transforming the Treatment Paradigm for SCLC

How New Research is Transforming the Treatment Paradigm for SCLC

Molly Li, MBBS, of the Chinese University of Hong Kong, joined Lung Cancers Today at the 2025 American Society of Clinical ...

IMforte Study Results from ASCO 2025 & WCLC 2025 by Dr. Stephen Liu

IMforte Study Results from ASCO 2025 & WCLC 2025 by Dr. Stephen Liu

Dr

Exploring tarlatamab in the DeLLphi-301 trial for small cell lung cancer

Exploring tarlatamab in the DeLLphi-301 trial for small cell lung cancer

Anna Minchom, MD, BCh, MB, MRCP, from The Royal Marsden Hospital, London, UK, discusses the investigation of tarlatamab in ...

IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)

IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)

In this episode of the Oncology Brothers podcast, we dive deep into the latest advancements in treating extensive stage small cell ...

164. ASCO 2025 - Lung Cancer with Dr. Ned McNamee

164. ASCO 2025 - Lung Cancer with Dr. Ned McNamee

In this episode,

Atezolizumab + Carboplatin/Etoposide for Extensive-Stage Small Cell Lung Cancer: IMpower133 Update

Atezolizumab + Carboplatin/Etoposide for Extensive-Stage Small Cell Lung Cancer: IMpower133 Update

As reported in the Journal of Clinical Oncology by Stephen V. Liu, MD, and colleagues, an updated overall survival analysis in the ...

Immunotherapy Advances Transform Small Cell Lung Cancer Care

Immunotherapy Advances Transform Small Cell Lung Cancer Care

Immunotherapy is changing treatment strategies for both limited- and extensive-stage small cell lung cancer, explained

Drug Discovery in Small Cell Lung Cancer: Triparna Sen, PhD, on New Developments and Data

Drug Discovery in Small Cell Lung Cancer: Triparna Sen, PhD, on New Developments and Data

Triparna Sen, PhD, joined Lung Cancers Today at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting to ...

IMpower010: adjuvant atezolizumab improves DFS in resected stage II-IIIA NSCLC

IMpower010: adjuvant atezolizumab improves DFS in resected stage II-IIIA NSCLC

Heather A. Wakelee, MD, Stanford University, Stanford, CA, talks on the findings of IMpower010, a Phase III global study of ...

Focus on Small Cell Lung Cancer Treatment in Kentucky

Focus on Small Cell Lung Cancer Treatment in Kentucky

... treatment advances for small cell lung cancer like the

Related Video Content

Create a Gmail account - Google Help information

Important: Before you set up a new Gmail account, make sure to sign out of your current Gmail account. Learn how to...

如何解决You must install .NET Desktop Runtime…… ? - 知乎 information

要关注的重点是上图中绿色方框标记的软件,是否题主所需要运行的。 假如,我是说假如,这个文件名“AacAmbientlighting.exe”的软件确实是题主所需要运行的软件的话,那么就需要按照蓝色方框中标 …

Download and install Google Chrome information

How to install Chrome Important: Before you download, check if Chrome supports your operating system and you’ve met...

Chegg Skills | Skills Programs for the Modern Workforce information

Since Chegg Skills, I've become a penetration tester and began my bachelor's in Cybersecurity. The support from the...

知乎 - 知乎 information

知乎,中文互联网高质量的问答社区和创作者聚集的原创内容平台,于 2011 年 1 月正式上线,以「让人们更好的分享知识、经验和见解,找到自己的解答」为品牌使命。知乎凭借认真、专业、友善的社区 …